A team of Canadian researchers at McMaster University is developing an inhalable TB vaccine that would act as a booster to strengthen immune protection right at the site of infection — the lungs. If successful, it would be among the first new effective TB vaccines in the world.
Other stories mentioning these organizations, people and topics
| Organizations: | McMaster University, Nunavut, Ottawa Hospital, Public Health Agency of Canada, Stop TB Canada, and TB Reach |
| People: | Gonzalo Alvarez, Harjit Sajjan, and Lena Faust |
| Topics: | COVID-19, pandemic, public health, tuberculosis, and vaccine |
Other News
Events For Leaders in
Science, Tech, Innovation, and Policy
Discuss and learn from those in the know at our virtual and in-person events.
See Upcoming Events
You have 0 free articles remaining.
Don't miss out - start your free trial today.
Start your FREE trial Already a member? Log in
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.